Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 21/12/20201 min de leitura
Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials; Public Meeting
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA, Agency, or we) is announcing a public meeting that will be convened by Duke University's Robert J. Margolis Center for Health Policy and supported by a cooperative agreement with FDA. The meeting, entitled "Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials," is intended to gather industry, patient, clinician, researcher, institutional review board, ethicist, professional society and other stakeholder input on the scientific and ethical issues that surround the inclusion of pregnant women in clinical trials for drug development.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →